Related Experiment Video
Updated: May 29, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Neuroprotective approaches: before and after delivery
Lina F Chalak1, Dwight J Rouse
1Division of Neonatal-Perinatal Medicine, Department of Pediatrics, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-9063, USA. lina.chalak@utsouthwestern.edu
Insights
Preterm infants face high cerebral palsy risks. This review explores antenatal and postnatal neuroprotective strategies, including magnesium sulfate, to mitigate these risks.
Area of Science:
- Neonatal neurology
- Developmental pediatrics
Background:
- Preterm birth is a significant risk factor for cerebral palsy.
- The risk of cerebral palsy increases as gestational age at birth decreases.
- Prematurity substantially contributes to the global burden of cerebral palsy.
Purpose of the Study:
- To review and discuss antenatal and postnatal neuroprotective strategies for preterm infants.
- To identify interventions targeting risk factors for cerebral palsy in this vulnerable population.
Main Methods:
- Literature review of antenatal and postnatal neuroprotective approaches.
- Discussion of specific interventions, including magnesium sulfate.
- Analysis of risk factors associated with cerebral palsy in preterm infants.
Main Results:
- Multiple risk factors contribute to cerebral palsy in preterm infants.
- Antenatal and postnatal interventions show potential for neuroprotection.
- Magnesium sulfate is highlighted as a potential neuroprotective agent.
Conclusions:
- Targeted neuroprotective strategies are crucial for preterm infants at risk of cerebral palsy.
- A combination of antenatal and postnatal approaches may offer the most benefit.
- Further research into optimizing neuroprotective interventions is warranted.
Abstract:
Infants born preterm are especially vulnerable to cerebral palsy, the risk of which is inversely proportional to gestational age at birth. The contribution of prematurity to the overall burden of cerebral palsy is substantial. This article reviews and discusses potential antenatal and postnatal neuroprotective approaches targeted at the numerous risk factors associated with cerebral palsy among preterm infants, including magnesium sulfate.
